Lantheus Holdings (LNTH) Cash from Operations (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Cash from Operations of 125127000.0 for Q1 2026, up 16.33% year-over-year from 107563000.0 in Q1 2025, and up 38.76% quarter-over-quarter from 90178000.0 in Q4 2025.
Lantheus Holdings (LNTH) Cash from Operations (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Cash from Operations for 13 consecutive years, with 125127000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 16.33% year-over-year to 125127000.0; the TTM figure through Mar 2026 stood at 407705000.0 (down 22.35% YoY), while the FY2025 annual figure was 390141000.0, down 28.38% from the prior year.
- Cash from Operations improved to 125127000.0 in Q1 2026 per LNTH's latest filing, from 90178000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 175062000.0 in Q3 2024 and bottomed at 32266000.0 in Q2 2023.
- Historically, Cash from Operations has averaged 96885823.53 across 5 years, with a median of 105352000.0 in 2022.
- Annual changes were most pronounced in 2022 — Cash from Operations jumped 2055.94% — and 2023, when it tumbled 144.45%.
- Lantheus Holdings' Cash from Operations stood at 105352000.0 in 2022, then advanced by 6.58% to 112287000.0 in 2023, then soared by 40.47% to 157730000.0 in 2024, then tumbled by 42.83% to 90178000.0 in 2025, then soared by 38.76% to 125127000.0 in 2026.
- Business Quant data shows LNTH's Cash from Operations at 125127000.0 in Q1 2026, 90178000.0 in Q4 2025, and 105294000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 92.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 92.20 Mn |
| Jun 30, 2026 | 92.20 Mn |
| Mar 31, 2026 | 125.13 Mn |
| Mar 31, 2026 | 125.13 Mn |
| Dec 31, 2025 | 90.18 Mn |
| Dec 31, 2025 | 90.18 Mn |
| Sep 30, 2025 | 105.29 Mn |
| Sep 30, 2025 | 105.29 Mn |
| Jun 30, 2025 | 87.11 Mn |
| Jun 30, 2025 | 87.11 Mn |
| Mar 31, 2025 | 107.56 Mn |
| Mar 31, 2025 | 107.56 Mn |
| Dec 31, 2024 | 157.73 Mn |
| Dec 31, 2024 | 157.73 Mn |
| Sep 30, 2024 | 175.06 Mn |
| Sep 30, 2024 | 175.06 Mn |
| Jun 30, 2024 | 84.72 Mn |
| Jun 30, 2024 | 84.72 Mn |
| Mar 31, 2024 | 127.24 Mn |
| Mar 31, 2024 | 127.24 Mn |